116 related articles for article (PubMed ID: 21192969)
21. 5-HT6 receptor ligands and their antipsychotic potential.
Arnt J; Olsen CK
Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
[No Abstract] [Full Text] [Related]
22. 5-ht6 receptors.
Woolley ML; Marsden CA; Fone KC
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):59-79. PubMed ID: 14965245
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia.
Perez-García G; Meneses A
Behav Brain Res; 2008 Dec; 195(1):139-46. PubMed ID: 18723050
[TBL] [Abstract][Full Text] [Related]
24. Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions.
Russell MG; Dias R
Curr Top Med Chem; 2002 Jun; 2(6):643-54. PubMed ID: 12052198
[TBL] [Abstract][Full Text] [Related]
25. Current status of positron emission tomography radiotracers for serotonin receptors in humans.
Zimmer L; Le Bars D
J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
27. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors.
Sleight AJ; Boess FG; Bös M; Levet-Trafit B; Riemer C; Bourson A
Br J Pharmacol; 1998 Jun; 124(3):556-62. PubMed ID: 9647481
[TBL] [Abstract][Full Text] [Related]
29. The 5-HT syndrome and the drug discrimination paradigm in rats: application in behavioral studies on the central 5-HT system.
Ortmann R
Pharmacopsychiatry; 1985 Mar; 18(2):198-201. PubMed ID: 3875109
[TBL] [Abstract][Full Text] [Related]
30. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
31. Serotonin receptor subtypes: implications for psychopharmacology.
Cowen PJ
Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
[TBL] [Abstract][Full Text] [Related]
32. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
33. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in central 5-hydroxytryptamine receptor agonists and antagonists.
Arvidsson LE; Hacksell U; Glennon RA
Prog Drug Res; 1986; 30():365-471. PubMed ID: 3544048
[No Abstract] [Full Text] [Related]
35. Pharmacokinetics of 5-HT6 receptor ligands.
Mancinelli A
Int Rev Neurobiol; 2010; 94():153-72. PubMed ID: 21081206
[No Abstract] [Full Text] [Related]
36. Pharmacology of 5-HT6 receptors--Part 1. Preface.
Borsini F
Int Rev Neurobiol; 2010; 94():xi-xii. PubMed ID: 21081199
[No Abstract] [Full Text] [Related]
37. A review of central 5-HT receptors and their function.
Barnes NM; Sharp T
Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
[TBL] [Abstract][Full Text] [Related]
38. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor].
Lefebvre H
Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490
[No Abstract] [Full Text] [Related]
39. Neuropharmacology of 5-hydroxytryptamine1B/D receptor ligands.
Chopin P; Moret C; Briley M
Pharmacol Ther; 1994; 62(3):385-405. PubMed ID: 7972340
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Potential of 5-HT6 Receptor Agonists.
Karila D; Freret T; Bouet V; Boulouard M; Dallemagne P; Rochais C
J Med Chem; 2015 Oct; 58(20):7901-12. PubMed ID: 26099069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
